AAAAAA

   
Results: 1-21 |
Results: 21
Significant pelvic recurrence in high-risk pathologic stage I-IV endometrial carcinoma patients after adjuvant chemotherapy alone: Implications for adjuvant radiation therapy
Authors: Mundt, AJ McBride, R Rotmensch, J Waggoner, SE Yamada, SD Connell, PP
Citation: Aj. Mundt et al., Significant pelvic recurrence in high-risk pathologic stage I-IV endometrial carcinoma patients after adjuvant chemotherapy alone: Implications for adjuvant radiation therapy, INT J RAD O, 50(5), 2001, pp. 1145-1153
Surgery and postoperative radiation therapy in FIGO Stage IIIC endometrialcarcinoma
Authors: Mundt, AJ Murphy, KT Rotmensch, J Waggoner, SE Yamada, SD Connell, PP
Citation: Aj. Mundt et al., Surgery and postoperative radiation therapy in FIGO Stage IIIC endometrialcarcinoma, INT J RAD O, 50(5), 2001, pp. 1154-1160
Absence of major peripheral neuropathy in a phase II trial of ifosfamide with vinorelbine in patients with ovarian cancer previously treated with platinum and paclitaxel
Authors: Fleming, GF Waggoner, SE Rotmensch, J Langhauser, C
Citation: Gf. Fleming et al., Absence of major peripheral neuropathy in a phase II trial of ifosfamide with vinorelbine in patients with ovarian cancer previously treated with platinum and paclitaxel, AM J CL ONC, 24(1), 2001, pp. 52-57
Initial clinical experience with intensity-modulated whole-pelvis radiation therapy in women with gynecologic malignancies
Authors: Mundt, AJ Roeske, JC Lujan, AE Yamada, SD Waggoner, SE Fleming, G Rotmensch, J
Citation: Aj. Mundt et al., Initial clinical experience with intensity-modulated whole-pelvis radiation therapy in women with gynecologic malignancies, GYNECOL ONC, 82(3), 2001, pp. 456-463
Phase I trial of concomitant vinorelbine, paclitaxel, and pelvic irradiation in cervical carcinoma and other advanced pelvic malignancies
Authors: Mundt, AJ Rotmensch, J Waggoner, SE Yamada, D Langhauser, C Fleming, GF
Citation: Aj. Mundt et al., Phase I trial of concomitant vinorelbine, paclitaxel, and pelvic irradiation in cervical carcinoma and other advanced pelvic malignancies, GYNECOL ONC, 82(2), 2001, pp. 333-337
Outcome of endometrial carcinoma patients with involvement of the uterine serosa
Authors: Ashman, JB Connell, PP Yamada, D Rotmensch, J Waggoner, SE Mundt, AJ
Citation: Jb. Ashman et al., Outcome of endometrial carcinoma patients with involvement of the uterine serosa, GYNECOL ONC, 82(2), 2001, pp. 338-343
Radionuclide therapy for the treatment of microscopic ovarian carcinoma: An overview
Authors: Whitlock, JL Roeske, JC Dietz, ML Straus, CM Hines, JJ Horwitz, EP Reba, RC Rotmensch, J
Citation: Jl. Whitlock et al., Radionuclide therapy for the treatment of microscopic ovarian carcinoma: An overview, IND ENG RES, 39(9), 2000, pp. 3135-3139
Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies
Authors: Roeske, JC Lujan, A Rotmensch, J Waggoner, SE Yamada, D Mundt, AJ
Citation: Jc. Roeske et al., Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies, INT J RAD O, 48(5), 2000, pp. 1613-1621
Characteristics and outcome of endometrial carcinoma patients age 45 yearsand younger
Authors: Tran, BN Connell, PP Waggoner, S Rotmensch, J Mundt, AJ
Citation: Bn. Tran et al., Characteristics and outcome of endometrial carcinoma patients age 45 yearsand younger, AM J CL ONC, 23(5), 2000, pp. 476-480
Synchronous ovarian and endometrial malignancies
Authors: Castro, IM Connell, PP Waggoner, S Rotmensch, J Mundt, AJ
Citation: Im. Castro et al., Synchronous ovarian and endometrial malignancies, AM J CL ONC, 23(5), 2000, pp. 521-525
Age as a prognostic factor for recurrence in patients with endometrial carcinoma
Authors: Mundt, AJ Waggoner, S Yamada, D Rotmensch, J Connell, PP
Citation: Aj. Mundt et al., Age as a prognostic factor for recurrence in patients with endometrial carcinoma, GYNECOL ONC, 79(1), 2000, pp. 79-85
One versus two intracavitary brachytherapy applications in early-stage cervical cancer patients undergoing definitive radiation therapy
Authors: Rotmensch, J Connell, PP Yamada, D Waggoner, SE Mundt, AJ
Citation: J. Rotmensch et al., One versus two intracavitary brachytherapy applications in early-stage cervical cancer patients undergoing definitive radiation therapy, GYNECOL ONC, 78(1), 2000, pp. 32-38
Acute problems during low-dose-rate intracavitary brachytherapy for cervical carcinoma
Authors: Wollschlaeger, K Connell, PP Waggoner, S Rotmensch, J Mundt, AJ
Citation: K. Wollschlaeger et al., Acute problems during low-dose-rate intracavitary brachytherapy for cervical carcinoma, GYNECOL ONC, 76(1), 2000, pp. 67-72
Surgery and postoperative radiation therapy in stage II endometrial carcinoma
Authors: Calvin, DP Connell, PP Rotmensch, J Waggoner, S Mundt, AJ
Citation: Dp. Calvin et al., Surgery and postoperative radiation therapy in stage II endometrial carcinoma, AM J CL ONC, 22(4), 1999, pp. 338-343
Preoperative intracavitary brachytherapy in early-stage cervical carcinoma
Authors: Mundt, AJ Waggoner, S Herbst, A Rotmensch, J
Citation: Aj. Mundt et al., Preoperative intracavitary brachytherapy in early-stage cervical carcinoma, AM J CL ONC, 22(1), 1999, pp. 73-77
The significance of adnexal involvement in endometrial carcinoma
Authors: Connell, PP Rotmensch, J Waggoner, S Mundt, AJ
Citation: Pp. Connell et al., The significance of adnexal involvement in endometrial carcinoma, GYNECOL ONC, 74(1), 1999, pp. 74-79
Phase I trial of concomitant chemoradiotherapy for cervical cancer and other advanced pelvic malignancies
Authors: Mundt, AJ Rotmensch, J Waggoner, S Quiet, C Fleming, G
Citation: Aj. Mundt et al., Phase I trial of concomitant chemoradiotherapy for cervical cancer and other advanced pelvic malignancies, GYNECOL ONC, 72(1), 1999, pp. 45-50
External pelvic radiation therapy in stage IC endometrial carcinoma
Authors: Weiss, MF Connell, PP Waggoner, S Rotmensch, J Mundt, AJ
Citation: Mf. Weiss et al., External pelvic radiation therapy in stage IC endometrial carcinoma, OBSTET GYN, 93(4), 1999, pp. 599-602
In vivo ultrasonographic exposimetry: Human tissue-specific attenuation coefficients in the gynecologic examination - Discussion
Authors: Rotmensch, J Gabbe, SG Berkowitz, RL Siddiqi, TA
Citation: J. Rotmensch et al., In vivo ultrasonographic exposimetry: Human tissue-specific attenuation coefficients in the gynecologic examination - Discussion, AM J OBST G, 180(4), 1999, pp. 874-874
Race and clinical outcome in patients with carcinoma of the uterine cervixtreated with radiation therapy
Authors: Mundt, AJ Connell, PP Campbell, T Hwang, JH Rotmensch, J Waggoner, S
Citation: Aj. Mundt et al., Race and clinical outcome in patients with carcinoma of the uterine cervixtreated with radiation therapy, GYNECOL ONC, 71(2), 1998, pp. 151-158
Cervical cancer in the elderly treated with radiation therapy
Authors: Mitchell, PA Waggoner, S Rotmensch, J Mundt, AJ
Citation: Pa. Mitchell et al., Cervical cancer in the elderly treated with radiation therapy, GYNECOL ONC, 71(2), 1998, pp. 291-298
Risultati: 1-21 |